FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2917243362> ?p ?o ?g. }

• W2917243362 endingPage "588" @default.
• W2917243362 startingPage "577" @default.
• W2917243362 abstract "Background: Significant blood loss is still one of the most frequent complications in spinal surgery, which often necessitates blood transfusion. Massive perioperative blood loss and blood transfusion can create additional risks. Aprotinin, tranexamic acid (TXA), and epsilon-aminocaproic acid (EACA) are antifibrinolytics currently offered as prophylactic agents to reduce surgery-associated blood loss. The aim of this study was to evaluate the efficacy and safety of aprotinin, EACA, and low/high doses of TXA in spinal surgery, and assess the use of which agent is the most optimal intervention using the network meta-analysis (NMA) method. Methods: Five electronic databases were searched, including PubMed, Cochrane Library, ScienceDirect, Embase, and Web of Science, from the inception to March 1, 2018. Trials that were randomized and compared results between TXA, EACA, and placebo were identified. The NMA was conducted with software R 3.3.2 and STATA 14.0. Results: Thirty randomized controlled trial (RCT) studies were analyzed. Aprotinin (standardized mean difference [SMD]=−0.65, 95% credibility intervals [CrI;−1.25, −0.06]), low-dose TXA (SMD = −0.58, 95% CrI [−0.92, −0.25]), and high-dose TXA (SMD = −0.70, 95% CrI [−1.04, −0.36]) were more effective than the respective placebos in reducing intraoperative blood loss. Low-dose TXA (SMD = −1.90, 95% CrI [−3.32, −0.48]) and high-dose TXA (SMD = −2.31, 95% CrI [−3.75, −0.87]) had less postoperative blood loss. Low-dose TXA (SMD = −1.07, 95% CrI [−1.82, −0.31]) and high-dose TXA (SMD = −1.07, 95% CrI [−1.82, −0.31]) significantly reduced total blood loss. However, only high-dose TXA (SMD = −2.07, 95% CrI [−3.26, −0.87]) was more effective in reducing the amount of transfusion, and was significantly superior to low-dose TXA in this regard (SMD = −1.67, 95% CrI [−3.20, −0.13]). Furthermore, aprotinin (odds ratio [OR] = 0.16, 95% CrI [0.05, 0.54]), EACA (OR = 0.46, 95% CrI [0.22, 0.97]) and high dose of TXA (OR = 0.34, 95% CrI [0.19, 0.58]) had a significant reduction in transfusion rates. Antifibrinolytics did not show a significantly increased risk of postoperative thrombosis. Results of ranking probabilities indicated that high-dose TXA had the greatest efficacy and a relatively high safety level. Conclusions: The antifibrinolytic agents are able to reduce perioperative blood loss and transfusion requirement during spine surgery. And the high-dose TXA administration might be used as the optimal treatment to reduce blood loss and transfusion." @default.
• W2917243362 created "2019-03-02" @default.
• W2917243362 creator A5007704446 @default.
• W2917243362 creator A5035783693 @default.
• W2917243362 creator A5054975341 @default.
• W2917243362 creator A5064583717 @default.
• W2917243362 creator A5076007825 @default.
• W2917243362 creator A5079921749 @default.
• W2917243362 creator A5090283045 @default.
• W2917243362 date "2019-03-05" @default.
• W2917243362 modified "2023-10-18" @default.
• W2917243362 title "Efficacy and safety of antifibrinolytic agents in spinal surgery" @default.
• W2917243362 cites W1617328014 @default.
• W2917243362 cites W1841216485 @default.
• W2917243362 cites W1879508761 @default.
• W2917243362 cites W1948289543 @default.
• W2917243362 cites W1964524664 @default.
• W2917243362 cites W1969118658 @default.
• W2917243362 cites W1970715117 @default.
• W2917243362 cites W1976777675 @default.
• W2917243362 cites W1985810044 @default.
• W2917243362 cites W1990603027 @default.
• W2917243362 cites W1993824807 @default.
• W2917243362 cites W2001110165 @default.
• W2917243362 cites W2001884511 @default.
• W2917243362 cites W2007270179 @default.
• W2917243362 cites W2009699612 @default.
• W2917243362 cites W2011749594 @default.
• W2917243362 cites W2015070638 @default.
• W2917243362 cites W2019222462 @default.
• W2917243362 cites W2021739858 @default.
• W2917243362 cites W2022269460 @default.
• W2917243362 cites W2031873562 @default.
• W2917243362 cites W2042598817 @default.
• W2917243362 cites W2057317578 @default.
• W2917243362 cites W2065045390 @default.
• W2917243362 cites W2073820477 @default.
• W2917243362 cites W2075039980 @default.
• W2917243362 cites W2093338681 @default.
• W2917243362 cites W2096459479 @default.
• W2917243362 cites W2125435699 @default.
• W2917243362 cites W2137514160 @default.
• W2917243362 cites W2162741181 @default.
• W2917243362 cites W2166402838 @default.
• W2917243362 cites W2184996075 @default.
• W2917243362 cites W2236130351 @default.
• W2917243362 cites W2255020850 @default.
• W2917243362 cites W2321976020 @default.
• W2917243362 cites W2323717507 @default.
• W2917243362 cites W2526218277 @default.
• W2917243362 cites W2559214711 @default.
• W2917243362 cites W2569858832 @default.
• W2917243362 cites W2584147432 @default.
• W2917243362 cites W2588683575 @default.
• W2917243362 cites W2608751399 @default.
• W2917243362 cites W2726833819 @default.
• W2917243362 cites W2729711505 @default.
• W2917243362 cites W2739475180 @default.
• W2917243362 cites W2769213467 @default.
• W2917243362 cites W2769618637 @default.
• W2917243362 cites W2775290064 @default.
• W2917243362 cites W2792924542 @default.
• W2917243362 cites W4244740079 @default.
• W2917243362 doi "https://doi.org/10.1097/cm9.0000000000000108" @default.
• W2917243362 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6416000" @default.
• W2917243362 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30807356" @default.
• W2917243362 hasPublicationYear "2019" @default.
• W2917243362 type Work @default.
• W2917243362 sameAs 2917243362 @default.
• W2917243362 citedByCount "23" @default.
• W2917243362 countsByYear W29172433622019 @default.
• W2917243362 countsByYear W29172433622020 @default.
• W2917243362 countsByYear W29172433622021 @default.
• W2917243362 countsByYear W29172433622022 @default.
• W2917243362 countsByYear W29172433622023 @default.
• W2917243362 crossrefType "journal-article" @default.
• W2917243362 hasAuthorship W2917243362A5007704446 @default.
• W2917243362 hasAuthorship W2917243362A5035783693 @default.
• W2917243362 hasAuthorship W2917243362A5054975341 @default.
• W2917243362 hasAuthorship W2917243362A5064583717 @default.
• W2917243362 hasAuthorship W2917243362A5076007825 @default.
• W2917243362 hasAuthorship W2917243362A5079921749 @default.
• W2917243362 hasAuthorship W2917243362A5090283045 @default.
• W2917243362 hasBestOaLocation W29172433621 @default.
• W2917243362 hasConcept C126322002 @default.
• W2917243362 hasConcept C141071460 @default.
• W2917243362 hasConcept C142724271 @default.
• W2917243362 hasConcept C168563851 @default.
• W2917243362 hasConcept C204787440 @default.
• W2917243362 hasConcept C27081682 @default.
• W2917243362 hasConcept C2776478404 @default.
• W2917243362 hasConcept C2777278314 @default.
• W2917243362 hasConcept C2779637338 @default.
• W2917243362 hasConcept C2780014101 @default.
• W2917243362 hasConcept C2780799893 @default.
• W2917243362 hasConcept C2781436528 @default.
• W2917243362 hasConcept C2991743468 @default.
• W2917243362 hasConcept C31174226 @default.

• next